Literature DB >> 8707343

Expression and function of membrane regulators of complement on rat astrocytes in culture.

C A Rogers1, P Gasque, S J Piddlesden, N Okada, V M Holers, B P Morgan.   

Abstract

Human astrocytes express CD59, decay accelerating factor and membrane cofactor protein to restrict the damaging effect of complement (C) activation on their cell surface. 5I2 antigen (5I2 Ag) is the functional analogue of the latter two proteins in rats. We here demonstrate the surface expression on rat astrocytes of CD59 and 5I2 Ag and use sodium dodecyl sulphate-polyacrylamide gel electrophoresis and Western blotting to confirm their identity and to quantify expression. Rat CD59 (MW 20,000) was expressed at 720 x 10(3) molecules per cell and 5I2 Ag (MW 58,000 and 64,000) at 625 x 10(3) molecules per cell. Reverse transcription-polymerase chain reaction using specific oligonucleotide primers demonstrated expression of mRNA for each protein. Twenty-four-hour stimulation with inflammatory cytokines (interferon-gamma, tumour necrosis factor-alpha, interleukins-1 beta, -2 and -6) or phorbol myristate acetate had no significant effect on the level of expression of either protein as determined by Western blotting. Lysis caused by classical pathway activation of C in human or rat serum was enhanced by blocking the function of CD59 and 5I2 Ag on rat astrocytes with monoclonal antibodies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8707343      PMCID: PMC1456455          DOI: 10.1046/j.1365-2567.1996.d01-637.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  35 in total

1.  Activation of the classical complement pathway in brain tissue of Alzheimer patients.

Authors:  P L McGeer; H Akiyama; S Itagaki; E G McGeer
Journal:  Neurosci Lett       Date:  1989-12-15       Impact factor: 3.046

2.  Complement mediated serum cytotoxicity against oligodendrocytes: a comparison with other cells of the oligodendrocyte-type 2 astrocyte lineage.

Authors:  N J Scolding; B P Morgan; A K Campbell; D A Compston
Journal:  J Neurol Sci       Date:  1990-07       Impact factor: 3.181

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Immunocytochemical localization of the terminal complement complex in multiple sclerosis.

Authors:  D A Compston; B P Morgan; A K Campbell; P Wilkins; G Cole; N D Thomas; B Jasani
Journal:  Neuropathol Appl Neurobiol       Date:  1989 Jul-Aug       Impact factor: 8.090

5.  Primary cultures of murine astrocytes produce C3 and factor B, two components of the alternative pathway of complement activation.

Authors:  M Lévi-Strauss; M Mallat
Journal:  J Immunol       Date:  1987-10-01       Impact factor: 5.422

6.  Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system.

Authors:  I Sommer; M Schachner
Journal:  Dev Biol       Date:  1981-04-30       Impact factor: 3.582

7.  The role of complement in the pathogenesis of experimental allergic encephalomyelitis.

Authors:  C Linington; B P Morgan; N J Scolding; P Wilkins; S Piddlesden; D A Compston
Journal:  Brain       Date:  1989-08       Impact factor: 13.501

8.  Tissue distribution of HRF20, a novel factor preventing the membrane attack of homologous complement, and its predominant expression on endothelial cells in vivo.

Authors:  M Nose; M Katoh; N Okada; M Kyogoku; H Okada
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

9.  Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies.

Authors:  P Vanguri; C L Koski; B Silverman; M L Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

10.  CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.

Authors:  A Davies; D L Simmons; G Hale; R A Harrison; H Tighe; P J Lachmann; H Waldmann
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

View more
  5 in total

1.  Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms.

Authors:  Hua Zhang; Jeffrey L Bennett; A S Verkman
Journal:  Ann Neurol       Date:  2011-11-08       Impact factor: 10.422

2.  Expression of rat CD59: functional analysis confirms lack of species selectivity and reveals that glycosylation is not required for function.

Authors:  N K Rushmere; S Tomlinson; B P Morgan
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

3.  Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59.

Authors:  Hua Zhang; A S Verkman
Journal:  J Autoimmun       Date:  2014-03-31       Impact factor: 7.094

4.  Identification of an astrocyte cell population from human brain that expresses perforin, a cytotoxic protein implicated in immune defense.

Authors:  P Gasque; J Jones; S K Singhrao; B Morgan
Journal:  J Exp Med       Date:  1998-02-16       Impact factor: 14.307

5.  Functional interaction between Lypd6 and nicotinic acetylcholine receptors.

Authors:  Maria Arvaniti; Majbrit M Jensen; Neeraj Soni; Hong Wang; Anders B Klein; Nathalie Thiriet; Lars H Pinborg; Pretal P Muldoon; Jacob Wienecke; M Imad Damaj; Kristi A Kohlmeier; Marjorie C Gondré-Lewis; Jens D Mikkelsen; Morten S Thomsen
Journal:  J Neurochem       Date:  2016-08-15       Impact factor: 5.372

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.